Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Roferon-A | interferon alfa-2a | Hoffmann-La Roche Inc. | N-103145 DISCN | 1986-06-04 | 1 products |
Code | Description |
---|---|
S0145 | Injection, pegylated interferon alfa-2a, 180 mcg per ml |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Chronic hepatitis c | D019698 | EFO_0004220 | B18.2 | 6 | 63 | 62 | 61 | 32 | 216 |
Hepatitis c | D006526 | — | B19.2 | 6 | 33 | 40 | 23 | 11 | 105 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 12 | 27 | 18 | 40 | 13 | 102 |
Hiv infections | D015658 | EFO_0000764 | B20 | 11 | 22 | 10 | 6 | 3 | 47 |
Hepatitis b | D006509 | — | — | — | 5 | 6 | 3 | 8 | 21 |
Neoplasms | D009369 | — | C80 | 8 | 4 | — | 1 | — | 12 |
Hepacivirus | D016174 | — | — | — | 7 | 4 | 1 | 1 | 12 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 3 | 2 | 2 | 1 | 8 |
Chronic hepatitis | D006521 | — | K73.9 | 1 | 3 | 3 | 1 | — | 7 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 2 | 2 | 2 | 1 | 1 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 12 | 11 | 8 | — | 1 | 31 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 3 | 13 | 3 | — | 1 | 17 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | 6 | — | 6 | 12 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | 4 | 5 | — | — | 8 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | 5 | 1 | — | — | 7 |
Polycythemia vera | D011087 | — | D45 | 1 | 1 | 4 | — | — | 6 |
Essential thrombocythemia | D013920 | — | D47.3 | 1 | 2 | 1 | — | — | 4 |
Recurrence | D012008 | — | — | 1 | 2 | 3 | — | — | 4 |
Covid-19 | D000086382 | — | U07.1 | 2 | 3 | 1 | — | — | 3 |
Multiple myeloma | D009101 | — | C90.0 | — | 1 | 2 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 3 | — | — | — | 6 |
Kaposi sarcoma | D012514 | — | C46 | 3 | 2 | — | — | — | 5 |
Leukemia | D007938 | — | C95 | 2 | 2 | — | — | 1 | 4 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 4 | 4 | — | — | — | 4 |
Hepatitis d | D003699 | EFO_0007304 | — | — | 3 | — | — | — | 3 |
Fibrosis | D005355 | — | — | — | 1 | — | — | 2 | 3 |
Prostatic neoplasms | D011471 | — | C61 | — | 2 | — | — | — | 2 |
Adenocarcinoma | D000230 | — | — | — | 2 | — | — | — | 2 |
Carcinoma | D002277 | — | C80.0 | — | 2 | — | — | — | 2 |
Squamous cell carcinoma | D002294 | — | — | 1 | 1 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 7 | — | — | — | 1 | 8 |
Triple negative breast neoplasms | D064726 | — | — | 2 | — | — | — | — | 2 |
Psoriasis | D011565 | EFO_0000676 | L40 | 1 | — | — | — | — | 1 |
Anus neoplasms | D001005 | EFO_0003835 | C21 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Intravenous substance abuse | D015819 | — | — | — | — | — | — | 1 | 1 |
Medication adherence | D055118 | EFO_0006344 | — | — | — | — | — | 1 | 1 |
Progressive multifocal leukoencephalopathy | D007968 | EFO_0007455 | A81.2 | — | — | — | — | 1 | 1 |
Ascites | D001201 | HP_0001541 | R18 | — | — | — | — | 1 | 1 |
Esophageal and gastric varices | D004932 | EFO_0009545 | I85 | — | — | — | — | 1 | 1 |
Drug common name | Interferon alfa-2a |
INN | — |
Description | Pegylated interferon alfa-2a, sold under the brand name Pegasys among others, is medication used to treat hepatitis C and hepatitis B. For hepatitis C it is typically used together with ribavirin and cure rates are between 24 and 92%. For hepatitis B it may be used alone. It is given by injection under the skin.
|
Classification | Protein |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | 120608 |
ChEMBL ID | CHEMBL2108508 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00008 |
UNII ID | — |